Email This Article
Amgen-Immunex Deal Needs to Start Making Sense
By
Adam Feuerstein
12/14/01 - 11:05 AM EST
Sales of arthritis drug Enbrel need to skyrocket for the acquisition of Immunex to make sense.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,286.87 | 1,089.91 | 2,169.36 | 34.22 |
Oil *
72.24
|
|
UP
0.90
|
DOWN
2.02
|
DOWN
3.63
|
UP
0.30
|
10 Yr
3.42%
SPDR Gold
110.01
|
|
+0.01%
|
-0.18%
|
-0.17%
|
+0.88%
|
Data delayed 20 minutes |


Connect with TheStreet